Vinu George

Vinu George has a vast and progressive work experience in the pharmaceutical industry. Vinu currently holds the position of Vice President and Chief Global Pharmacovigilance Officer at Otsuka Pharmaceutical Companies (U.S.), a role they have been in since March 2022. Prior to this, they served as the Vice President and Global Head of Medical Safety, and later as the Executive Director and Global Head of Medical Safety at the same company. Before joining Otsuka, Vinu worked as the Senior Director and US Head of Medical Safety. Vinu started their career at Otsuka Pharmaceuticals Development and Commercialization, Inc. in 2015 as the Director and CNS Therapeutic Area Lead. Previously, they held the role of Associate Director, Clinical Safety and Pharmacovigilance at Otsuka Pharmaceutical Development and Commercialization, Inc. Vinu also gained experience at Forest Research Institute, Inc., where they served as an Associate Director of Clinical Development. Vinu started their professional journey at Albert Einstein Medical Center as the Associate Residency Program Director in Psychiatry.

Vinu George has a strong educational background in the field of medicine. Vinu obtained an MD degree in Psychiatry from Albert Einstein Medical Center, where they studied from 2004 to 2008. Prior to that, they completed their MBBS degree from St. John's Medical College, graduating between 1993 and 1998. In addition to their academic qualifications, Vinu George has also obtained certifications in Business Strategy from McKinsey & Company and is affiliated with the American Board of Psychiatry and Neurology.